Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haploidentical PBSC Transplantation for Severe Congenital Anemias
NCT00977691Phase 2Active, not recruiting
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Dec 2009
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in sickle cell anemia (SCA), beta thalassemia, sponsored by National Heart, Lung, and Blood Institute. Started Dec 2009; status: active, not recruiting.
02
Drugs
cyclophosphamide
03
Conditions
sickle cell anemia (SCA)beta thalassemia
Beyond the preview
Go deeper on NCT00977691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00977691.